Shi‐Dong Luo

Pharmacophore Modelling and Virtual Screening for Identification of New Aurora‐A Kinase Inhibitors

Xiaoqiang Deng, Huiyuan Wang, Yinglan Zhao et al. · Chemical Biology & Drug Design · 2008 · 49 citations

Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors

Huiyuan Wang, Zhixing Cao, Linli Li et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 28 citations · Full text

Medicinal Chemistry, Virtual Screening, Drug Target +6

SKLB610: A Novel Potential Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Inhibits Angiogenesis and Tumor Growth <i>in Vivo</i>

Zhixing Cao, Renlin Zheng, Hongjun Lin et al. · Cellular Physiology and Biochemistry · 2011 · 25 citations

SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both <i>In Vitro</i> and <i>In Vivo</i>

Youli Pan, Yong Xu, Shan Feng et al. · Molecular Cancer Therapeutics · 2012 · 22 citations

Tumor Biology, Oncology, Novel Therapy +15

A Specific Pharmacophore Model of Aurora B Kinase Inhibitors and Virtual Screening Studies Based on it

Huiyuan Wang, Linli Li, Zhixing Cao et al. · Chemical Biology & Drug Design · 2008 · 15 citations